Industry News
NHMRC provides high-level research programs
Nine medical research programs provided through the NHMRC have been announced, and they will help boost Australia's reputation as an international leader in research.
[ + ]MASSIVE to allow for research in 3D
A new supercomputer facility, MASSIVE, will help the study of conditions such as asthma, cystic fibrosis and diabetes by allowing researchers to capture and view data in 3D.
[ + ]Feature: Top down proteomics
Professor Neil Kelleher is driving to make top down proteomics a more efficient and productive approach. [ + ]
Feature: From proteomics to biomarkers
Professor Neil Kelleher is using his top down proteomics approach to discover new biomarkers for disease. [ + ]
Antibacterial sales to decline
Despite a number of new hospital brands to be launched targeting serious infections caused by multidrug-resistant bacteria, there will be a market decline caused by genericisation, safety concerns and resistance of leading antibacterial brands.
[ + ]The Goldilocks mechanism of immune regulation
Australian researchers have discovered a subset of regulatory T cells that keep the immune system in a fine balance. [ + ]
Computational science expert awarded UQ fellowship
Professor John Quackenbush has been offered an Australian Fellowship to join the University of Queensland's Institute for Molecular Bioscience.
[ + ]Clinuvel to begin trial of Scenesse in US and Europe
Pilot trials of Clinuvel’s skin repigmentation treatment, Scenesse (afamelanotide), will begin in the US and Europe to treat vitiligo. [ + ]
Scientists and biotechs opposed to biologics patent amendment
The Australian Academy of Science and AusBiotech have both spoken out against the proposed amendment to the patent act that would ban patenting any biological materials. [ + ]
International Year of Chemistry highlights importance of water
The United Nations has declared 2011 the International Year of Chemistry, which includes an international initiative that highlights the role chemistry plays in issues of water quality and purification.
[ + ]Government accepts report by Clinical Trials Action Group
The recommendations of the Clinical Trials Action Group have been accepted by the federal government, and the changes will have a positive effect on pharmaceutical research and development and will improve the clinical trials approval process.
[ + ]Australian government to overhaul clinical trials
The federal government will overhaul the clinical trials process in Australia after accepting recommendations of the long awaited Clinical Trials Action Group report. [ + ]
Australian stem cell researchers call for less regulatory red tape
The licensing system for creating stem cells is preventing potentially life saving research and should be streamlined, say Australian stem cell researchers. [ + ]
Immuron granted patent for anti-influenza product
Australian patent issued for Imm-255, which is an orally administered anti-influenza candidate. [ + ]
